The impact of type 2 diabetes on the development of tendinopathy.

advanced glycation end-products hyperglycaemia insulin resistance obesity tendinopathy type 2 diabetes

Journal

Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450

Informations de publication

Date de publication:
09 2021
Historique:
revised: 11 09 2020
received: 08 06 2020
accepted: 23 09 2020
pubmed: 7 11 2020
medline: 5 1 2022
entrez: 6 11 2020
Statut: ppublish

Résumé

Tendinopathy is a chronic and often painful condition affecting both professional athletes and sedentary subjects. It is a multi-etiological disorder caused by the interplay among overload, ageing, smoking, obesity (OB) and type 2 diabetes (T2D). Several studies have identified a strong association between tendinopathy and T2D, with increased risk of tendon pain, rupture and worse outcomes after tendon repair in patients with T2D. Moreover, consequent immobilization due to tendon disorder has a strong impact on diabetes management by reducing physical activity and worsening the quality of life. Multiple investigations have been performed to analyse the causal role of the individual metabolic factors occurring in T2D on the development of tendinopathy. Chronic hyperglycaemia, advanced glycation end-products, OB and insulin resistance have been shown to contribute to the development of diabetic tendinopathy. This review aims to explore the relationship between tendinopathy and T2D, in order to define the contribution of metabolic factors involved in the degenerative process and to discuss possible strategies for the clinical management of diabetic tendinopathy.

Identifiants

pubmed: 33156563
doi: 10.1002/dmrr.3417
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3417

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

O'Brien M. The anatomy of the Achilles tendon. Foot Ankle Clin. 2005;10(2):225-238.
Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409-416.
Pujalte GG, Silvis ML. The injured runner. Med Clin North Am. 2014;98(4):851-868.
Federer AE, Steele JR, Dekker TJ, Liles JL, Adams SB. Tendonitis and tendinopathy: what are they and how do they evolve? Foot Ankle Clin. 2017;22(4):665-676.
Magnusson SP, Hansen M, Langberg H, et al. The adaptability of tendon to loading differs in men and women. Int J Exp Pathol. 2007;88(4):237-240.
Abate M, Salini V, Andia I. How obesity affects tendons? Adv Exp Med Biol. 2016;920:167-177.
Lundgreen K, Lian OB, Scott A, Nassab P, Fearon A, Engebretsen L. Rotator cuff tear degeneration and cell apoptosis in smokers versus nonsmokers. Arthroscopy. 2014;30(8):936-941.
Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford). 2004;43(2):131-142.
Ranger TA, Wong AM, Cook JL, Gaida JE. Is there an association between tendinopathy and diabetes mellitus? A systematic review with meta-analysis. Br J Sports Med. 2016;50(16):982-989.
Cahn A, Cernea S, Raz I. Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes. Rev Endocr Metab Disord. 2016;17(1):117-127.
IDF, IDF Diabetes Atlas. 8th. 2017. http://www.diabetesatlas.org.
Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208-219.
Hothersall EJ, Livingstone SJ, Looker HC, et al. Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland. J Bone Min Res. 2014;29(5):1054-1060.
Asadian L, Haddadi K, Aarabi M, Zare A. Diabetes mellitus, a new risk factor for lumbar spinal stenosis: a case-control study. Clin Med Insights Endocrinol Diabetes. 2016;9:1-5.
Cannata F, Vadala G, Ambrosio L, et al. Intervertebral disc degeneration: a focus on obesity and type 2 diabetes. Diabetes Metab Res Rev. 2020;36(1):e3224.
Cannata F, Vadala G, Ambrosio L, et al. Osteoarthritis and type 2 diabetes: from pathogenetic factors to therapeutic intervention. Diabetes Metab Res Rev. 2020;36(3):e3254.
Napoli N, Conte C, Pedone C, et al. Effect of insulin resistance on BMD and fracture risk in older adults. J Clin Endocrinol Metab. 2019;104(8):3303-3310.
Ursini F, Arturi F, D'Angelo S, et al. High prevalence of achilles tendon enthesopathic changes in patients with type 2 diabetes without peripheral neuropathy. J Am Podiatr Med Assoc. 2017;107(2):99-105.
Hill NE, Roscoe D, Stacey MJ, Chew S. Cheiroarthropathy and tendinopathy in diabetes. Diabet Med. 2019;36(8):939-947.
Ackermann PW, Hart DA. General overview and summary of concepts regarding tendon disease topics addressed related to metabolic disorders. Adv Exp Med Biol. 2016;920:293-298.
Malliaras P, Cook J. Patellar tendons with normal imaging and pain: change in imaging and pain status over a volleyball season. Clin J Sport Med. 2006;16(5):388-391.
Alfredson H, Ljung BO, Thorsen K, Lorentzon R. In vivo investigation of ECRB tendons with microdialysis technique--no signs of inflammation but high amounts of glutamate in tennis elbow. Acta Orthop Scand. 2000;71(5):475-479.
Lui PPY. Tendinopathy in diabetes mellitus patients-Epidemiology, pathogenesis, and management. Scand J Med Sci Sports. 2017;27(8):776-787.
Partridge L, Rajbhandari S. Achilles tendon in diabetes. Curr Diabetes Rev. 2017;13(4):424-427.
Abate M, Salini V, Schiavone C. Achilles tendinopathy in elderly subjects with type II diabetes: the role of sport activities. Aging Clin Exp Res. 2016;28(2):355-358.
Zakaria MH, Davis WA, Davis TM. Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study. Diabet Med. 2014;31(4):425-430.
Nichols AEC, Oh I, Loiselle AE. Effects of type II diabetes mellitus on tendon homeostasis and healing. J Orthop Res. 2020;38(1):13-22.
Leong HT, Fu SC, He X, Oh JH, Yamamoto N, Hang S. Risk factors for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med. 2019;51(9):627-637.
Blonna D, Fissore F, Bellato E, et al. Subclinical hypothyroidism and diabetes as risk factors for postoperative stiff shoulder. Knee Surg Sports Traumatol Arthrosc. 2017;25(7):2208-2216.
Akturk M, Karaahmetoglu S, Kacar M, Muftuoglu O. Thickness of the supraspinatus and biceps tendons in diabetic patients. Diabetes Care. 2002;25(2):408.
Cho NS, Moon SC, Jeon JW, Rhee YG. The influence of diabetes mellitus on clinical and structural outcomes after arthroscopic rotator cuff repair. Am J Sports Med. 2015;43(4):991-997.
Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabet Complicat. 2010;24(3):154-162.
Kameyama M, Chen KR, Mukai K, Shimada A, Atsumi Y, Yanagimoto S. Histopathological characteristics of stenosing flexor tenosynovitis in diabetic patients and possible associations with diabetes-related variables. J Hand Surg Am. 2013;38(7):1331-1339.
Snedeker JG, Foolen J. Tendon injury and repair - a perspective on the basic mechanisms of tendon disease and future clinical therapy. Acta Biomater 2017;63:18-36.
Clement ND, Hallett A, MacDonald D, Howie C, McBirnie J. Does diabetes affect outcome after arthroscopic repair of the rotator cuff? J Bone Joint Surg Br. 2010;92(8):1112-1117.
Volper BD, Huynh RT, Arthur KA, et al. Influence of acute and chronic streptozotocin-induced diabetes on the rat tendon extracellular matrix and mechanical properties. Am J Physiol Regul Integr Comp Physiol. 2015;309(9):R1135-R1143.
Oliveira RR, Medina de Mattos R, Magalhaes Rebelo L, et al. Experimental diabetes alters the morphology and nano-structure of the achilles tendon. PLoS One. 2017;12(1):e0169513.
David MA, Jones KH, Inzana JA, Zuscik MJ, Awad HA, Mooney RA. Tendon repair is compromised in a high fat diet-induced mouse model of obesity and type 2 diabetes. PLoS One. 2014;9(3):e91234.
Tsai WC, Liang FC, Cheng JW, et al. High glucose concentration up-regulates the expression of matrix metalloproteinase-9 and -13 in tendon cells. BMC Musculoskelet Disord. 2013;14:255.
Ueda Y, Inui A, Mifune Y, et al. The effects of high glucose condition on rat tenocytes in vitro and rat Achilles tendon in vivo. Bone Joint Res. 2018;7(5):362-372.
Poulsen RC, Knowles HJ, Carr AJ, Hulley PA. Cell differentiation versus cell death: extracellular glucose is a key determinant of cell fate following oxidative stress exposure. Cell Death Dis. 2014;5:e1074.
Abate M, Schiavone C, Salini V, Andia I. Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford). 2013;52(4):599-608.
Wu YF, Wang HK, Chang HW, Sun J, Sun JS, Chao YH. High glucose alters tendon homeostasis through downregulation of the AMPK/Egr1 pathway. Sci Rep. 2017;7:44199.
Lin YC, Li YJ, Rui YF, et al. The effects of high glucose on tendon-derived stem cells: implications of the pathogenesis of diabetic tendon disorders. Oncotarget. 2017;8(11):17518-17528.
Kwan CK, Fu SC, Yung PS. A high glucose level stimulate inflammation and weaken pro-resolving response in tendon cells - a possible factor contributing to tendinopathy in diabetic patients. Asia Pac J Sports Med Arthrosc Rehabil Technol. 2020;19:1-6.
Nusca A, Tuccinardi D, Albano M, et al. Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab Res Rev. 2018;34(8):e3047.
Papalia R, Moro L, Franceschi F, et al. Endothelial dysfunction and tendinopathy: how far have we come? Musculoskelet Surg. 2013;97(3):199-209.
Makrantonaki E, Jiang D, Hossini AM, et al. Diabetes mellitus and the skin. Rev Endocr Metab Disord. 2016;17(3):269-282.
Zhang W, Randell EW, Sun G, et al. Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes. PLoS One. 2017;12(9):e0184105.
Li Y, Fessel G, Georgiadis M, Snedeker JG. Advanced glycation end-products diminish tendon collagen fiber sliding. Matrix Biol 2013;32(3-4):169-177.
Bourne JW, Lippell JM, Torzilli PA. Glycation cross-linking induced mechanical-enzymatic cleavage of microscale tendon fibers. Matrix Biol 2014;34:179-184.
Rosenthal AK, Gohr CM, Mitton E, Monnier V, Burner T. Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes. J Investig Med. 2009;57(2):460-466.
Belkin AM. Extracellular TG2: emerging functions and regulation. FEBS J. 2011;278(24):4704-4716.
Lee JM, Veres SP. Advanced glycation end-product cross-linking inhibits biomechanical plasticity and characteristic failure morphology of native tendon. J Appl Physiol (1985). 2019;126(4):832-841.
Patel SH, Yue F, Saw SK, et al. Advanced glycation end-products suppress mitochondrial function and proliferative capacity of achilles tendon-derived fibroblasts. Sci Rep. 2019;9(1):12614.
Xu L, Xu K, Wu Z, et al. Pioglitazone attenuates advanced glycation end products-induced apoptosis and calcification by modulating autophagy in tendon-derived stem cells. J Cell Mol Med. 2020;24(3):2240-2251.
Docheva D, Muller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv Drug Deliv Rev. 2015;84:222-239.
Ahmed AS, Li J, Schizas N, et al. Expressional changes in growth and inflammatory mediators during Achilles tendon repair in diabetic rats: new insights into a possible basis for compromised healing. Cell Tissue Res. 2014;357(1):109-117.
Reddy GK. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues. J Orthop Res. 2003;21(4):738-743.
Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med. 2017;15(1):131.
Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for Plantar fasciitis: a matched case-control study. J Bone Joint Surg Am. 2003;85(5):872-877.
Galli MM, Protzman NM, Mandelker EM, Malhotra A, Schwartz E, Brigido SA. Comparing tendinous and ligamentous ankle pathology in atraumatic overweight and nonoverweight patients: a comprehensive MRI review. Foot Ankle Spec. 2014;7(6):449-456.
Scott RT, Hyer CF, Granata A. The correlation of Achilles tendinopathy and body mass index. Foot Ankle Spec. 2013;6(4):283-285.
Klein EE, Weil L, Jr., Weil LS, Sr, Fleischer AE. Body mass index and Achilles tendonitis: a 10-year retrospective analysis. Foot Ankle Spec. 2013;6(4):276-282.
Fairley J, Toppi J, Cicuttini FM, et al. Association between obesity and magnetic resonance imaging defined patellar tendinopathy in community-based adults: a cross-sectional study. BMC Musculoskelet Disord. 2014;15:266.
Nantel J, Mathieu ME, Prince F. Physical activity and obesity: biomechanical and physiological key concepts. J Obes. 2011;2011:650230.
Rechardt M, Shiri R, Karppinen J, Jula A, Heliovaara M, Viikari-Juntura E. Lifestyle and metabolic factors in relation to shoulder pain and rotator cuff tendinitis: a population-based study. BMC Musculoskelet Disord. 2010;11:165.
Gumina S, Candela V, Passaretti D, et al. The association between body fat and rotator cuff tear: the influence on rotator cuff tear sizes. J Shoulder Elb Surg. 2014;23(11):1669-1674.
Shiri R, Viikari-Juntura E, Varonen H, Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065-1074.
Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab. 2007;32(1):4-12.
Mancuso P. The role of adipokines in chronic inflammation. Immunotargets Ther. 2016;5:47-56.
Rothan HA, Suhaeb AM, Kamarul T. Recombinant human adiponectin as a potential protein for treating diabetic tendinopathy promotes tenocyte progenitor cells proliferation and tenogenic differentiation in vitro. Int J Med Sci. 2013;10(13):1899-1906.
Ji J, wang Z, Shi D, Gao X, Jiang Q. Pathologic changes of Achilles tendon in leptin-deficient mice. Rheumatol Int. 2010;30(4):489-493.
Beason DP, Abboud JA, Kuntz AF, Bassora R, Soslowsky LJ. Cumulative effects of hypercholesterolemia on tendon biomechanics in a mouse model. J Orthop Res. 2011;29(3):380-383.
Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H, Cook JL. Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Med Sci Sports Exerc. 2009;41(6):1194-1197.
Abboud JA, Kim JS. The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res. 2010;468(6):1493-1497.
Mathiak G, Wening JV, Mathiak M, Neville LF, Jungbluth K. Serum cholesterol is elevated in patients with Achilles tendon ruptures. Arch Orthop Trauma Surg. 1999;119(5-6):280-284.
Lehner C, Gehwolf R, Wagner A, et al. Tendons from non-diabetic humans and rats harbor a population of insulin-producing, pancreatic beta cell-like cells. Horm Metab Res. 2012;44(7):506-510.
Studentsova V, Mora KM, Glasner MF, Buckley MR, Loiselle AE. Obesity/type II diabetes promotes function-limiting changes in murine tendons that are not reversed by restoring normal metabolic function. Sci Rep. 2018;8(1):9218.
Mazzocca AD, McCarthy MB, Chowaniec D, et al. Bone marrow-derived mesenchymal stem cells obtained during arthroscopic rotator cuff repair surgery show potential for tendon cell differentiation after treatment with insulin. Arthroscopy. 2011;27(11):1459-1471.
Iossi MF, Konstantakos EK, Teel DD, 2nd, et al. Musculoskeletal function following bariatric surgery. Obesity (Silver Spring). 2013;21(6):1104-1110.
Abate M, Salini V, Antinolfi P, Schiavone C. Ultrasound morphology of the Achilles in asymptomatic patients with and without diabetes. Foot Ankle Int. 2014;35(1):44-49.
Langberg H, Skovgaard D, Karamouzis M, Bulow J, Kjaer M. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol. 1999;515(Pt 3):919-927.
Kubo K, Yajima H, Takayama M, Ikebukuro T, Mizoguchi H, Takakura N. Effects of acupuncture and heating on blood volume and oxygen saturation of human Achilles tendon in vivo. Eur J Appl Physiol. 2010;109(3):545-550.
Greve K, Domeij-Arverud E, Labruto F, et al. Metabolic activity in early tendon repair can be enhanced by intermittent pneumatic compression. Scand J Med Sci Sports. 2012;22(4):e55-63.
Rees J, Gaida JE, Silbernagel KG, Zwerver J, Anthony JS, Scott A. Rehabilitation of tendon problems in patients with diabetes mellitus. Adv Exp Med Biol. 2016;920:199-208.
Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008;466(7):1539-1554.
Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-1767.
Grandizio LC, Speeckaert A, Brothers J, Graham J, Klena JC. Predictors of recurrence after corticosteroid injection for trigger digits. Hand (N Y). 2017;12(4):352-356.
Roh YH, Oh M, Noh JH, Gong HS, Baek GH. Effect of metabolic syndrome on the functional outcome of corticosteroid injection for lateral epicondylitis: retrospective matched case-control study. Sci Rep. 2017;7(1):10845.
Kim N, Schroeder J, Hoffler CE, Matzon JL, Lutsky KF, Beredjiklian PK. Elevated hemoglobin A1C levels correlate with blood glucose elevation in diabetic patients following local corticosteroid injection in the hand: a prospective study. Plast Reconstr Surg. 2015;136(4):474e-479e.
Bussey MR, Emanuele MA, Lomasney LM, Tehrani R. Sitagliptin-induced bilateral Achilles tendinitis. Rheumatology (Oxford). 2014;53(4):630.
Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395-2410.

Auteurs

Francesca Cannata (F)

Department of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Gianluca Vadalà (G)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy.

Luca Ambrosio (L)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy.

Nicola Napoli (N)

Department of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Rocco Papalia (R)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy.

Vincenzo Denaro (V)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy.

Paolo Pozzilli (P)

Department of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH